What You Should Know:
- Atropos Health, the pioneer in translating real-world clinical data into personalized real-world evidence and insights, today announced a partnership with Every Cure, a nonprofit initiative on a mission to unlock the full potential of existing medicines to treat every disease and every patient they possibly can so that patients don’t suffer while cures hide on the pharmacy shelf.
- The collaboration allows Every Cure to leverage GENEVA OS™ and data from the Atropos Evidence™ Network to confirm and enhance findings from their AI driven data platform in the real world. By doing this, it offers key real world signals and generation of AI model features to emulate the effect of therapies in real world populations. This rapid, high quality evidence generation dramatically accelerates the potential of yielding new uses for existing drugs and can accelerate clinical development by providing a real-world signal of patient response.
Unlocking the Full Potential of Modern Medicine
Since its inception in 2023, the collaboration has pioneered a Real-World Data-driven approach named “Biology-in-Data Out” and “Data-in-Biology Out.” This method, employed by Every Cure, involves utilizing their AI platform to identify potential drug repurposing signals, which are then validated in real-world patients through the GENEVA OS and the Atropos Evidence Network. Recently featured in a Cell Publication by Dr. Dylan Dodd at Stanford University, this approach utilizes Atropos Health to confirm the impact of the antibiotic Bactrim on gout symptoms by analyzing shifts in gut bacteria populations.
Coinciding with the launch of Geneva OS™ and ChatRWD™, Atropos Health, a leader in life sciences, has also formed a Life Sciences Advisory Board featuring executives from prominent pharmaceutical companies such as Moderna and Novartis. Every Cure and other partners gain access to Atropos’ evidence generation tools through a federated installation of Geneva OS in their internal cloud data environment. This includes the Green Button Informatics Consult and access to Alexandria™, housing thousands of existing studies for rerunning on local data. Furthermore, Geneva OS incorporates the CRAFT Emulation Toolkit™, allowing users to enhance trial recruitment and analyze trial designs in real-world data, facilitating diverse subgroup analysis for optimizing study designs. CRAFT Emulation Toolkit accelerates evidence generation, maintaining Atropos Health’s commitment to swift insights.
